Y.D. More Investments’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Y.D. More Investments’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$267K	Hold	2,700	–	–	0.01%	215
2026 Q1	$234K	Hold	2,700	–	–	0.01%	194
2025 Q4	$229K	Hold	2,700	–	–	0.01%	191
2025 Q3	$196K	Hold	2,700	–	–	0.01%	201
2025 Q2	$177K	Hold	2,700	–	–	0.01%	215
2025 Q1	$191K	Hold	2,700	–	–	0.02%	205
2024 Q4	$177K	Hold	2,700	–	–	0.02%	197
2024 Q3	$191K	Hold	2,700	–	–	0.02%	196
2024 Q2	$179K	Buy	2,700 +1,152	+74%	+$75.5K	0.02%	189
2024 Q1	$105K	Hold	1,548	–	–	0.02%	200
2023 Q4	$95.7K	Buy	1,548 +348	+29%	+$20.5K	0.02%	205
2023 Q3	$70.8K	Hold	1,200	–	–	0.01%	220
2023 Q2	$71.6K	Hold	1,200	–	–	0.02%	197
2023 Q1	$70.1K	Hold	1,200	–	–	0.02%	197
2022 Q4	$74.7K	Buy	+1,200	New	+$72.2K	0.02%	226

Other funds holding IHE

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Y.D. More Investments's IHE Position: Q2 2026 in Review

Y.D. More Investments held its iShares US Pharmaceuticals ETF (IHE) position steady in Q2 2026 at 2,700 shares worth $267K. The position accounts for 0.01% of the portfolio, ranked #215.

Y.D. More Investments first reported a position in IHE in Q4 2022 and has held it in 15 quarters since. 210 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

Y.D. More Investments held 2,700 shares of iShares US Pharmaceuticals ETF worth $267K as of Q2 2026.
Y.D. More Investments left its iShares US Pharmaceuticals ETF share count unchanged in Q2 2026.
iShares US Pharmaceuticals ETF made up 0.01% of Y.D. More Investments's portfolio in Q2 2026, its #215 holding.
Y.D. More Investments first reported a position in iShares US Pharmaceuticals ETF in Q4 2022 and has held it in 15 quarters since.
210 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on Y.D. More Investments's 13F filing for Q2 2026, filed 5 Aug 2026.